Multiple Myeloma Treatment Strategies with Novel Agents in 2011: A European Perspective

The arrival of the novel agents thalidomide, bortezomib, and lenalidomide has significantly changed our approach to the management of multiple myeloma and, importantly, patient outcomes have improved. These agents have been investigated intensively in different treatment settings, providing us with...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Ludwig, Heinz, Beksac, Meral, Bladé, Joan, Cavenagh, Jamie, Cavo, Michele, Delforge, Michel, Dimopoulos, Meletios, Drach, Johannes, Einsele, Hermann, Facon, Thierry, Goldschmidt, Hartmut, Harousseau, Jean-Luc, Hess, Urs, Kropff, Martin, Leal da Costa, Fernando, Louw, Vernon, Magen-Nativ, Hila, Mendeleeva, Larisa, Nahi, Hareth, Plesner, Torben, San-Miguel, Jesús, Sonneveld, Pieter, Udvardy, Miklos, Sondergeld, Pia, Palumbo, Antonio
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AlphaMed Press 2011
Aiheet:
Academia-Pharma Intersect
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228121/
https://ncbi.nlm.nih.gov/pubmed/21441574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0386
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia